We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$414M
AUM Growth
+$975K
Cap. Flow
-$20.5M
Cap. Flow %
-4.96%
Top 10 Hldgs %
95.09%
Holding
24
New
3
Increased
8
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$1.72M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$794K
3
PACB icon
Pacific Biosciences
PACB
+$464K
4
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$449K
5
AMRN
Amarin Corp
AMRN
+$263K

Top Sells

Rank Stock Value
1
MZOR
Mazor Robotics Ltd.
MZOR
+$14.2M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$5.79M
3
EPZM
Epizyme, Inc
EPZM
+$4.19M
4
TSRO
TESARO, Inc.
TSRO
+$3.94M
5
AXDX
Accelerate Diagnostics
AXDX
+$3.88M

Sector Composition

Rank Sector Weight
1 Healthcare 99.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$157M 38.01%
2,364,883
+28,435
+1% +$1.72M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$95.3M 23.04%
427,408
-17,354
-4% -$3.88M
PACB icon
3
Pacific Biosciences
PACB
$432M
$34.5M 8.33%
9,704,761
+167,100
+2% +$464K
TSRO
4
DELISTED
TESARO, Inc.
TSRO
$34M 8.21%
763,535
-81,183
-10% -$3.94M
OPK icon
5
Opko Health
OPK
$1.25B
$17.3M 4.19%
3,686,194
– –
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$16.5M 4%
1,393,743
+63,673
+5% +$794K
AMRN
7
Amarin Corp
AMRN
$293M
$16.3M 3.93%
263,067
+4,243
+2% +$263K
VRML
8
DELISTED
Vermillion, Inc.
VRML
$7.67M 1.85%
9,825,289
– –
BIOL
9
DELISTED
Biolase, Inc.
BIOL
$7.47M 1.81%
2,469
– –
CFRX
10
DELISTED
ContraFect Corporation
CFRX
$7.13M 1.72%
4,031
+72
+2% +$106K
SLNO
11
DELISTED
Soleno Therapeutics
SLNO
$5.71M 1.38%
162,537
+3,333
+2% +$97.7K
AGEN
12
Agenus
AGEN
$275M
$3.4M 0.82%
76,402
-2,438
-3% -$164K
AXDX
13
CALL
DELISTED
Accelerate Diagnostics
AXDX
$2.11M 0.51%
60,760
+9,120
+18% +$2.04M
KDNY
14
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.08M 0.5%
59,409
+11,713
+25% +$449K
BIIB icon
15
Biogen
BIIB
$30.4B
$1.85M 0.45%
6,368
– –
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.74M 0.42%
39,887
-134,638
-77% -$5.79M
EPZM
17
DELISTED
Epizyme, Inc
EPZM
$1.72M 0.42%
127,143
-269,182
-68% -$4.19M
MZOR
18
CALL
DELISTED
Mazor Robotics Ltd.
MZOR
$697K 0.17%
+135,300
New +$7.82M
QDEL icon
19
CALL
QuidelOrtho
QDEL
$1.14B
$660K 0.16%
105,700
-92,600
-47% -$5.6M
ARNA
20
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$295K 0.07%
+100,000
New +$4.3M
TSRO
21
CALL
DELISTED
TESARO, Inc.
TSRO
$66K 0.02%
+11,000
New +$534K
BMY icon
22
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-776,900
Closed -$1.2M
VANI icon
23
Vivani Medical
VANI
$113M
– –
-2,117
Closed -$98K
MZOR
24
DELISTED
Mazor Robotics Ltd.
MZOR
– –
-246,317
Closed -$14.2M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Oracle Investment Management held 24 positions worth $414M, up 0.24% from $413M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management withdrew a net $20.5M in Q2 2018, closing 3 positions and reducing 6 holdings. Its most notable exit was Mazor Robotics Ltd., an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 95% a quarter earlier.

Against the trend, Oracle Investment Management added an estimated $1.72M to QuidelOrtho.

  • Oracle Investment Management added most to QuidelOrtho in Q2 2018, an estimated $1.72M increase.
  • Oracle Investment Management's biggest Q2 2018 reduction was Arena Pharmaceuticals Inc, cutting an estimated $5.79M.
  • Oracle Investment Management fully exited Mazor Robotics Ltd. in Q2 2018, selling an estimated $14.2M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $414M portfolio in Q2 2018.
  • Oracle Investment Management opened 3 new positions and closed 3 in Q2 2018.
  • Oracle Investment Management's portfolio value rose 0.24% quarter-over-quarter to $414M.

Based on Oracle Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.